-
Mashup Score: 4FDA Drops REMS Requirement for Antihypertensive Aprocitentan - 15 hour(s) ago
The drug was approved last year for patients with hypertension currently not controlled on other BP-lowering agents.
Source: www.tctmd.comCategories: General Medicine NewsTweet
-
Mashup Score: 6
Though ischemic outcomes numerically favored the Amulet, confirmation in future studies is needed, experts say.
Source: www.tctmd.comCategories: General Medicine NewsTweet-
SWISS-APERO at 3 Years: Hints of Differences Between Amulet, Watchman Emerge https://t.co/zq1M4soWLZ https://t.co/ehpKK8uWMv
-
-
Mashup Score: 1FDA Drops REMS Requirement for Antihypertensive Aprocitentan - 15 hour(s) ago
The drug was approved last year for patients with hypertension currently not controlled on other BP-lowering agents.
Source: www.tctmd.comCategories: General Medicine NewsTweet-
FDA Drops REMS Requirement for Antihypertensive Aprocitentan https://t.co/5PMb2tEZew https://t.co/9dNJQ9o7Kq
-
-
Mashup Score: 0The SCOFF Trial - 16 hour(s) ago
David Ferreira talks to C. Michael Gibson about the latest data showing patients don’t need to fast ahead of cardiac catheterization.
Source: www.tctmd.comCategories: General Medicine NewsTweet-
The SCOFF Trial https://t.co/LKRTSh25kq https://t.co/jMwbFCFUyv
-
-
Mashup Score: 0AHA Tackles Need for Increased CV Prevention in Emerging Adults - 18 hour(s) ago
The transition from adolescence can bring decreased physical activity, a worse diet, and little focus on overall CV health.
Source: www.tctmd.comCategories: General Medicine NewsTweet-
AHA Tackles Need for Increased CV Prevention in Emerging Adults https://t.co/3OmKUIt9qS https://t.co/W3e4AkVJWt
-
-
Mashup Score: 9Post-TAVI Pacemaker Tied to Poorer Long-term Outcomes - 2 day(s) ago
Whether newer pacing techniques can mitigate death, LV decline, and HF symptoms in TAVI patients remains to be seen.
Source: www.tctmd.comCategories: General Medicine NewsTweet-
Post-TAVI Pacemaker Tied to Poorer Long-term Outcomes https://t.co/1M2T6kBCYq https://t.co/1H9BRqPAEd
-
-
Mashup Score: 2
For every 100,000 runners who complete the full 42.2 km distance, there will be one cardiac arrest, new data show.
Source: www.tctmd.comCategories: General Medicine NewsTweet-
RACER: No Change in Cardiac Arrests During Marathons, but Survival Is Up https://t.co/bF7O3nQkzs https://t.co/3q0NUHsL5w
-
-
Mashup Score: 2Positive Results With Volt Pulsed-Field Ablation System - 3 day(s) ago
The system, which has received CE Mark approval in Europe, adds to an increasingly crowded field of PFA technologies.
Source: www.tctmd.comCategories: General Medicine NewsTweet-
Positive Results With Volt Pulsed-Field Ablation System https://t.co/hUPqgVxsru https://t.co/vXdAvmbMD3
-
-
Mashup Score: 42Beyond the Data: The SOUL Trial - 3 day(s) ago
Mamas Mamas, Matthew Cavender, and Michael Blaha discuss the impact of oral semaglutide use for type 2 diabetes patients with ASCVD and/or CKD.
Source: www.tctmd.comCategories: General Medicine NewsTweet-
Mamas Mamas (@mmamas1973), Matthew Cavender, and Michael Blaha (@MichaelJBlaha) discuss SOUL trial results and how they will impact diabetic patients seeking an oral drug. #ACC25 Watch the full video: https://t.co/bqNBVdU6fN https://t.co/aAFcWb1xRw
-
-
Mashup Score: 0
AI outperformed clinicians and almost matched hs-TnT testing, but one expert questioned if this is where it’s needed most.
Source: www.tctmd.comCategories: General Medicine NewsTweet-
AI Shows Promise in Detecting Type 1 MI and Need for Revascularization https://t.co/fsp0aRcWQe https://t.co/MeUusRHV1S
-
US FDA (@US_FDA) removes the REMS requirement from aprocitentan (Tryvio), as announced by @IdorsiaUS. Read the full update: https://t.co/Q3lyW1GU0z https://t.co/IUyyHVRH9e